(-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo
about
BH3 mimetics to improve cancer therapy; mechanisms and examplesSIRT3 and cancer: tumor promoter or suppressor?Neoplasia: Where We Have Been and Where We Are GoingNeoplasia: the second decade.Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancerThe G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.Gossypol increases expression of the pro-apoptotic BH3-only protein NOXA through a novel mechanism involving phospholipase A2, cytoplasmic calcium, and endoplasmic reticulum stress.PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cellsAn open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer.Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models.Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer.(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101)Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1.Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells.Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis.In vivo evaluation of AT-101 (R-(-)-gossypol acetic acid) in androgen-independent growth of VCaP prostate cancer cells in combination with surgical castrationFusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo.HOXC6 is deregulated in human head and neck squamous cell carcinoma and modulates Bcl-2 expressionBroad targeting of resistance to apoptosis in cancer.Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefitProtection of dietary polyphenols against oral cancer.Mobilization of Intracellular Copper by Gossypol and Apogossypolone Leads to Reactive Oxygen Species-Mediated Cell Death: Putative Anticancer MechanismInhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol.Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effectsExpanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents.A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer.AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis.R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells.Small-molecule inhibitors reveal a new function for Bcl-2 as a proangiogenic signaling molecule.Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy.(±)-Gossypol induces apoptosis and autophagy in head and neck carcinoma cell lines and inhibits the growth of transplanted salivary gland cancer cells in BALB/c mice.AT-101 inhibits hedgehog pathway activity and cancer growth.Integrative Medicine in Head and Neck Cancer.Autophagy in Cancer Therapy.The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells.Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer.ABT-737 synergizes with chemotherapy to kill head and neck squamous cell carcinoma cells via a Noxa-mediated pathway.
P2860
Q24655483-5646F60A-1145-4DF5-ABDD-9737145869D0Q28390097-26479688-26B9-4EE7-B7DB-520E01792196Q28395095-5F68672F-163E-459F-BAD6-8895905802E2Q30484000-ABDDFFA3-D91C-4A79-B7B9-64E879783DE3Q30983828-48C80E78-7B14-4ED3-B416-D1024C918EBCQ33623170-1C23C4D8-1460-42A2-A94D-583C569318B9Q33718487-922557E9-1BCF-40F3-A6BB-BFFF40A4DF00Q33857728-8791BA66-2738-4A4F-8F0B-8871B8C30E1BQ34066960-07E3C0F9-564D-4339-9185-A016B3E45479Q34687012-36DAD966-B029-4461-9022-E47A7B27651EQ35050748-62FA186C-D14B-417B-B7B4-07996ACF60E1Q35582270-984F851D-17FD-47A9-8A74-9E4ED5C665FEQ35595711-565FF95B-4FFB-4344-A8AD-2F4B9F50E0ECQ35605849-9D638773-1F0D-429E-B914-541BF4882B13Q35620470-6B3F577F-C31C-4F3B-A2E2-57EAF34696DAQ36088627-906076D8-F701-459C-A03E-BE2FAD9FCC09Q36237274-35A0F708-AD89-45AE-B5B1-C826EA714CF5Q36259619-8DB3DC78-57F8-4914-85B2-2A9FE7B3769BQ36283436-0E63BACF-F9AE-43DF-9924-C0F348862E4DQ36318646-6C984216-6F94-496D-9CDA-ADF3CDBF47A4Q36483749-64D27ED2-8BF1-4CD9-8982-AA58D39FAA80Q36541458-AF2DB916-DF2A-4CAB-B551-B82D8AB66001Q36713669-7AE3FD8E-418C-4CE1-A014-21C73EA857CFQ37050854-70638C3D-3E5F-441A-98E6-CB6C7DF64CE8Q37050884-C931FAC6-2207-42A9-8E0A-3E207AED0E5BQ37084443-B49DF2B7-FAB7-4732-A351-8D75890F1400Q37109324-F4AD29CD-1823-42A3-A664-56809FE9EAAAQ37124747-013A338C-BBFD-4DC1-9536-3F5F675EE1C7Q37284056-CA594930-4B66-45B7-B120-200B8B07B70CQ37406947-6B5DF6AB-F66D-4955-A65B-D05C1FBAC2C1Q37523208-6920FF6D-95CD-4431-AEFD-4E9F2914C385Q37799747-F74D7D9C-8F66-40DA-B9C6-BB7591FD8DB6Q38331755-CB72FC0C-9261-4392-8CAF-AF46073BD0C4Q38743654-ED97BC0D-BFBF-4983-9520-3ABD2E27CFB1Q38859894-1F30C2C1-AD11-4D4D-9655-3C6CB49A5D53Q38978329-D4DCBF7B-E8BE-42A0-A6B6-2EF71E803C48Q39412865-F06B5B8B-8967-46B8-B193-82C8408EE1D4Q39466656-C4B0FC29-7762-4F55-B30B-8BE013E1C877Q39733063-C07F3767-5920-4390-9672-971EF03CE756Q39879308-2935838D-86FC-4786-824A-48723CA01B5A
P2860
(-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
(-)-gossypol inhibits growth a ...... quamous cell carcinoma in vivo
@ast
(-)-gossypol inhibits growth a ...... quamous cell carcinoma in vivo
@en
type
label
(-)-gossypol inhibits growth a ...... quamous cell carcinoma in vivo
@ast
(-)-gossypol inhibits growth a ...... quamous cell carcinoma in vivo
@en
prefLabel
(-)-gossypol inhibits growth a ...... quamous cell carcinoma in vivo
@ast
(-)-gossypol inhibits growth a ...... quamous cell carcinoma in vivo
@en
P2093
P2860
P356
P1433
P1476
(-)-gossypol inhibits growth a ...... quamous cell carcinoma in vivo
@en
P2093
Bhavna Kumar
Bradley S Henson
Carol R Bradford
Jianyong Chen
Keith G Wolter
Kent A Griffith
Nisha J D'Silva
Shaomeng Wang
Steven J Wang
P2860
P304
P356
10.1593/NEO.05691
P577
2006-03-01T00:00:00Z